Calliditas promotes Andrew Udell to President, North America

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that former Head of North America Commercial, Andrew Udell, has been promoted to President, North America, effective immediately.

“Andrew has been instrumental in the growth of the US operations over the last 12 months and has done a great job of creating a strong connection between the US and European teams throughout this period of high growth. He is an experienced leader, and I am delighted to continue to work with him in this new role,” said CEO Renee Aguiar-Lucander.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...